Samitib 400mg Tablet
In stock
Description
Samitib 400 mg is a pharmaceutical tablet containing Imatinib Mesylate, which is used as a targeted therapy for various cancers and blood disorders. It functions primarily as a tyrosine kinase inhibitor.
Specifications
| Strength | 400mg |
|---|---|
| Uses | Blood Cancer |
| Packaging | 30 tablets |
| Shelf Life | 2 years |
| Dosage Form | Tablet (oral) |
